FDA OKs Boston Scientific's Spectra WaveWriter SCS System [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
FDA OKs Boston Scientific's Spectra WaveWriter SCS SystemThe FDAapproves Boston Scientific's (NYSE:BSX) Spectra WaveWriter Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. The company says it is the only approved SCS device that simultaneously provides paresthesia (tingling or numbness)-based and sub-perception therapy enabling patients to customize their pain management therapy.SCS works by sending low electrical pulse of varying frequency, pulse width and amplitude to the spinal cord to interrupt pain signals.Click to subscribe to real-time analytics on BSXNow read:Boston Scientific (BSX) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow »
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- Peripheral Vascular Stent Market is Expected to Reach an Estimated US$ 8,878.00 million by 2034 with a CAGR of 7.60% from 2024 to 2034 | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors [Yahoo! Finance]Yahoo! Finance
- Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Global Veterinary Ultrasound Research Report 2024: Market to Surpass $500 Million by 2030 - Focus on Improving Livestock Health in Emerging Countries Presents Untapped Growth Opportunities [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 1/31/24 - Miss
BSX
Sec Filings
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BSX's page on the SEC website